Immucell (ICCC) Revenue Growth (5y) (2015 - 2026)
Analysis
Immucell (ICCC) Revenue Growth (5y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.57 Bn | 40.38 Bn | 779.09 Mn |
| 2 | Zoetis | 30.57 Bn | 28.90 Bn | 1.05 Bn |
| 3 | Elanco Animal Health | 11.47 Bn | 10.94 Bn | 798.00 Mn |
| 4 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 134.40 Mn |
| 5 | Immucell | 87.38 Mn | 78.52 Mn | 2.44 Mn |
| 6 | Zhengye Biotechnology Holding | 64.40 Mn | 57.30 Mn | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.61% |
| Dec 31, 2025 | 15.29% |
| Sep 30, 2025 | 8.14% |
| Jun 30, 2025 | 16.79% |
| Mar 31, 2025 | 10.44% |
| Dec 31, 2024 | 16.37% |
| Sep 30, 2024 | 15.14% |
| Jun 30, 2024 | 15.09% |
| Mar 31, 2024 | 10.47% |
| Sep 30, 2023 | 20.17% |
| Jun 30, 2023 | 3.22% |
| Mar 31, 2023 | 3.65% |
| Dec 31, 2022 | 4.54% |
| Sep 30, 2022 | 19.06% |
| Jun 30, 2022 | 17.15% |
| Mar 31, 2022 | 11.10% |
| Dec 31, 2021 | 19.72% |
| Sep 30, 2021 | 21.21% |
| Jun 30, 2021 | 13.84% |
| Mar 31, 2021 | 6.58% |